We are pleased to announce that our research consortium is now a member of the Digital Health and Discovery Platform (DHDP).
This platform is a pan-Canadian initiative that brings precision medicine and personalized care to patients with cancer and neurodegenerative disease through the application of big data and artificial intelligence.
As a key stakeholder in the evolution of health care in Quebec, our Group is proud to collaborate with the DHDP to improve patient care by advancing precision medicine in the treatment of breast cancer.
“Similarly to what our Group has accomplished, we are proud to participate in the DHDP platform which will create a ‘network effect’ to accelerate the adoption of innovative treatments”, comments Dominique Johnson, Managing Director of the McPeak-Sirois Group.
Find out more in Dominique Johnson’s interview below